These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38528637)

  • 1. Cellular and molecular mechanisms involved in the analgesic effects of botulinum neurotoxin: A literature review.
    Hosseindoost S; Inanloo SH; Pestehei SK; Rahimi M; Yekta RA; Khajehnasiri A; Rad MA; Majedi H; Dehpour AR
    Drug Dev Res; 2024 Apr; 85(2):e22177. PubMed ID: 38528637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The analgesic effects of botulinum neurotoxin by modulating pain-related receptors; A literature review.
    Hosseindoost S; Askari Rad M; Inanloo SH; Rahimi M; Dehghan S; Orandi A; Dehpour AR; Majedi H
    Mol Pain; 2024; 20():17448069241275099. PubMed ID: 39093638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception.
    Kim DW; Lee SK; Ahnn J
    Toxins (Basel); 2015 Jun; 7(7):2435-53. PubMed ID: 26134255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analgesic potential of clostridial neurotoxin derivatives.
    Foster KA
    Expert Opin Investig Drugs; 2004 Nov; 13(11):1437-43. PubMed ID: 15500391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain.
    Bagues A; Hu J; Alshanqiti I; Chung MK
    Pharmacol Ther; 2024 Jul; 259():108668. PubMed ID: 38782121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes.
    Marinelli S; Vacca V; Ricordy R; Uggenti C; Tata AM; Luvisetto S; Pavone F
    PLoS One; 2012; 7(10):e47977. PubMed ID: 23110146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal selectivity of botulinum neurotoxins.
    Poulain B; Lemichez E; Popoff MR
    Toxicon; 2020 Apr; 178():20-32. PubMed ID: 32094099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status and future directions of botulinum neurotoxins for targeting pain processing.
    Pellett S; Yaksh TL; Ramachandran R
    Toxins (Basel); 2015 Nov; 7(11):4519-63. PubMed ID: 26556371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum Toxin for Neuropathic Pain: A Review of the Literature.
    Oh HM; Chung ME
    Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospects.
    Pickett A
    BioDrugs; 2010 Jun; 24(3):173-82. PubMed ID: 20462283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons.
    Restani L; Giribaldi F; Manich M; Bercsenyi K; Menendez G; Rossetto O; Caleo M; Schiavo G
    PLoS Pathog; 2012 Dec; 8(12):e1003087. PubMed ID: 23300443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
    Moritz MS; Tepp WH; Bradshaw M; Johnson EA; Pellett S
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin for pain management: insights from animal models.
    Pavone F; Luvisetto S
    Toxins (Basel); 2010 Dec; 2(12):2890-913. PubMed ID: 22069581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin A, brain and pain.
    Matak I; Lacković Z
    Prog Neurobiol; 2014; 119-120():39-59. PubMed ID: 24915026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum Toxin Type A in Dental Medicine.
    Muñoz Lora VRM; Del Bel Cury AA; Jabbari B; Lacković Z
    J Dent Res; 2019 Dec; 98(13):1450-1457. PubMed ID: 31533008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Toxin Type A-A Modulator of Spinal Neuron-Glia Interactions under Neuropathic Pain Conditions.
    Rojewska E; Piotrowska A; Popiolek-Barczyk K; Mika J
    Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29614835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum Neurotoxins and Cancer-A Review of the Literature.
    Mittal SO; Jabbari B
    Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31948115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
    Pellett S; Tepp WH; Bradshaw M; Kalb SR; Dykes JK; Lin G; Nawrocki EM; Pier CL; Barr JR; Maslanka SE; Johnson EA
    mSphere; 2016; 1(1):. PubMed ID: 27303710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum Toxin and Pain.
    Lacković Z
    Handb Exp Pharmacol; 2021; 263():251-264. PubMed ID: 32016565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling.
    Pellett S; Tepp WH; Scherf JM; Johnson EA
    PLoS One; 2015; 10(7):e0133737. PubMed ID: 26207366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.